Repoldo, Baby Girl R.
HRN: 46 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/09/2022
AMPICILLIN 250MG (VIAL)
04/09/2022
04/16/2022
IV
155mg
Q12h
PNSB; NB Affected By Maternal UTI / Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Non-compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes